For research use only. Not for therapeutic Use.
Tizanidine-d4 (CAS: 1188331-19-2), a premium pharmaceutical research compound designed for advanced studies in muscle relaxant and neurology research. As a deuterated analog of Tizanidine, it offers enhanced stability and improved pharmacokinetic properties. Tizanidine-d4 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for muscle spasticity and neurological conditions. Trusted by leading laboratories, Tizanidine-d4 is your go-to solution for cutting-edge muscle relaxant research. Unlock new possibilities in muscle spasticity treatment with Tizanidine-d4, where innovation meets reliability.
| Catalog Number | S000112 |
| CAS Number | 1188331-19-2 |
| Molecular Formula | C9H4D4ClN5S |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| IUPAC Name | 5-chloro-N-(4,4,5,5-tetradeuterio-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine |
| InChI | InChI=1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13)/i3D2,4D2 |
| InChIKey | XFYDIVBRZNQMJC-KHORGVISSA-N |
| SMILES | [2H]C1(C(N=C(N1)NC2=C(C=CC3=NSN=C32)Cl)([2H])[2H])[2H] |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Kamen L, et al. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin. 2008 Feb;24(2):425-39. |
